PMID- 31234910
OWN - NLM
STAT- MEDLINE
DCOM- 20191227
LR  - 20210930
IS  - 1756-994X (Electronic)
IS  - 1756-994X (Linking)
VI  - 11
IP  - 1
DP  - 2019 Jun 24
TI  - Integrating informatics tools and portable sequencing technology for rapid 
      detection of resistance to anti-tuberculous drugs.
PG  - 41
LID - 10.1186/s13073-019-0650-x [doi]
LID - 41
AB  - BACKGROUND: Mycobacterium tuberculosis resistance to anti-tuberculosis drugs is a 
      major threat to global public health. Whole genome sequencing (WGS) is rapidly 
      gaining traction as a diagnostic tool for clinical tuberculosis settings. To 
      support this informatically, previous work led to the development of the widely 
      used TBProfiler webtool, which predicts resistance to 14 drugs from WGS data. 
      However, for accurate and rapid high throughput of samples in clinical or 
      epidemiological settings, there is a need for a stand-alone tool and the ability 
      to analyse data across multiple WGS platforms, including Oxford Nanopore MinION. 
      RESULTS: We present a new command line version of the TBProfiler webserver, which 
      includes hetero-resistance calling and will facilitate the batch processing of 
      samples. The TBProfiler database has been expanded to incorporate 178 new markers 
      across 16 anti-tuberculosis drugs. The predictive performance of the mutation 
      library has been assessed using >â€‰17,000 clinical isolates with WGS and 
      laboratory-based drug susceptibility testing (DST) data. An integrated MinION 
      analysis pipeline was assessed by performing WGS on 34 replicates across 3 
      multi-drug resistant isolates with known resistance mutations. TBProfiler 
      accuracy varied by individual drug. Assuming DST as the gold standard, 
      sensitivities for detecting multi-drug-resistant TB (MDR-TB) and extensively 
      drug-resistant TB (XDR-TB) were 94% (95%CI 93-95%) and 83% (95%CI 79-87%) with 
      specificities of 98% (95%CI 98-99%) and 96% (95%CI 95-97%) respectively. Using 
      MinION data, only one resistance mutation was missed by TBProfiler, involving an 
      insertion in the tlyA gene coding for capreomycin resistance. When compared to 
      alternative platforms (e.g. Mykrobe predictor TB, the CRyPTIC library), 
      TBProfiler demonstrated superior predictive performance across first- and 
      second-line drugs. CONCLUSIONS: The new version of TBProfiler can rapidly and 
      accurately predict anti-TB drug resistance profiles across large numbers of 
      samples with WGS data. The computing architecture allows for the ability to 
      modify the core bioinformatic pipelines and outputs, including the analysis of 
      WGS data sourced from portable technologies. TBProfiler has the potential to be 
      integrated into the point of care and WGS diagnostic environments, including in 
      resource-poor settings.
FAU - Phelan, Jody E
AU  - Phelan JE
AD  - Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical 
      Medicine, London, WC1E 7HT, UK.
FAU - O'Sullivan, Denise M
AU  - O'Sullivan DM
AD  - Molecular Biology, LGC Ltd, Queens Road, Teddington, Middlesex, TW11 0LY, UK.
FAU - Machado, Diana
AU  - Machado D
AD  - Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina 
      Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Lisbon, Portugal.
FAU - Ramos, Jorge
AU  - Ramos J
AD  - Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina 
      Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Lisbon, Portugal.
FAU - Oppong, Yaa E A
AU  - Oppong YEA
AD  - Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical 
      Medicine, London, WC1E 7HT, UK.
FAU - Campino, Susana
AU  - Campino S
AD  - Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical 
      Medicine, London, WC1E 7HT, UK.
FAU - O'Grady, Justin
AU  - O'Grady J
AD  - Norwich Medical School, University of East Anglia, Norwich Research Park, 
      Norwich, NR4 7TJ, UK.
FAU - McNerney, Ruth
AU  - McNerney R
AD  - Department of Medicine, University of Cape Town, Observatory, Cape Town, 7925, 
      South Africa.
FAU - Hibberd, Martin L
AU  - Hibberd ML
AD  - Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical 
      Medicine, London, WC1E 7HT, UK.
FAU - Viveiros, Miguel
AU  - Viveiros M
AD  - Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina 
      Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Lisbon, Portugal.
FAU - Huggett, Jim F
AU  - Huggett JF
AD  - Molecular Biology, LGC Ltd, Queens Road, Teddington, Middlesex, TW11 0LY, UK.
AD  - School of Biosciences & Medicine, Faculty of Health & Medical Science, University 
      of Surrey, Guildford, GU2 7XH, UK.
FAU - Clark, Taane G
AU  - Clark TG
AUID- ORCID: 0000-0001-8985-9265
AD  - Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical 
      Medicine, London, WC1E 7HT, UK. taane.clark@lshtm.ac.uk.
AD  - Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina 
      Tropical, IHMT, Universidade NOVA de Lisboa, UNL, Lisbon, Portugal. 
      taane.clark@lshtm.ac.uk.
AD  - Faculty of Epidemiology and Population Health, London School of Hygiene & 
      Tropical Medicine, London, WC1E 7HT, UK. taane.clark@lshtm.ac.uk.
LA  - eng
GR  - MR/N010469/1/MRC_/Medical Research Council/United Kingdom
GR  - BB/R013063/1/BB_/Biotechnology and Biological Sciences Research Council/United 
      Kingdom
GR  - MR/R025576/1/MRC_/Medical Research Council/United Kingdom
GR  - MR/R020973/1/MRC_/Medical Research Council/United Kingdom
GR  - MR/N013956/1/MRC_/Medical Research Council/United Kingdom
GR  - MR/M01360X/1/MRC_/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190624
PL  - England
TA  - Genome Med
JT  - Genome medicine
JID - 101475844
RN  - 0 (Antitubercular Agents)
SB  - IM
MH  - Antitubercular Agents/pharmacology
MH  - *Drug Resistance, Microbial
MH  - Genome, Bacterial
MH  - Humans
MH  - Molecular Diagnostic Techniques/*methods
MH  - Mycobacterium tuberculosis/drug effects/*genetics
MH  - Point-of-Care Testing
MH  - *Software
MH  - Tuberculosis, Multidrug-Resistant/diagnosis/*microbiology
MH  - Whole Genome Sequencing/*methods
PMC - PMC6591855
OTO - NOTNLM
OT  - Diagnostics
OT  - Drug resistance
OT  - Drug-susceptibility testing
OT  - MDR-TB
OT  - Tuberculosis
OT  - WGS
OT  - XDR-TB
COIS- The authors declare that they have no competing interests. There is no competing 
      interest for authors affiliated to LGC.
EDAT- 2019/06/27 06:00
MHDA- 2019/12/28 06:00
PMCR- 2019/06/24
CRDT- 2019/06/26 06:00
PHST- 2019/04/08 00:00 [received]
PHST- 2019/05/30 00:00 [accepted]
PHST- 2019/06/26 06:00 [entrez]
PHST- 2019/06/27 06:00 [pubmed]
PHST- 2019/12/28 06:00 [medline]
PHST- 2019/06/24 00:00 [pmc-release]
AID - 10.1186/s13073-019-0650-x [pii]
AID - 650 [pii]
AID - 10.1186/s13073-019-0650-x [doi]
PST - epublish
SO  - Genome Med. 2019 Jun 24;11(1):41. doi: 10.1186/s13073-019-0650-x.
